Application value of serum biomarkers for choosing memantine therapy for moderate AD

This study suggests that the logistic regression model (LRM) and the ROC curve based on patients’ serum levels of VEGF, BDNF, IL-6 and IL-1β is a promising research for diagnosing and choosing the best course of treatment for moderate AD.
Source: Journal of Neurology - Category: Neurology Source Type: research